Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXVN8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,640
Award facts
- Contract value 100% obligated
- $27,640.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,640.12 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on January 27, 2026, with completion scheduled for January 28, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military treatment facilities. The supply of Zepbound, a diabetes and weight management medication, reflects the company's extensive portfolio encompassing specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the routine fulfillment of medical commodities through DLA's pharmaceutical supply chain supporting the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FXVN8?
SPE2DR26FXVN8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FXVN8 worth?
The government has obligated $27,640 on SPE2DR26FXVN8.
Is contract SPE2DR26FXVN8 an order under another contract?
Yes. SPE2DR26FXVN8 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVN8 competed?
The extent of competition for SPE2DR26FXVN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award